Rare cancers, despite their low incidence, collectively represent a significant portion of all cancer cases. Research is vital because it can lead to the development of novel therapies and improve survival rates for these patients. Without dedicated research, patients with rare cancers may face poorer outcomes compared to those with more common cancers.
